H.R. 2077 · 109th Congress
To suspend temporarily the duty on Garenoxacin mesylate.
- Stage
- In committee
- Sponsor
- Kevin Brady
- Introduced
- 2005-05-04
- Latest action
- 2005-05-10 · Referred to the Subcommittee on Trade.
Summary
Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2008, the duty on 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-5-isoindolyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate monohydrate (Garenoxacin mesylate).